Skip to main navigation Skip to search Skip to main content

A Phase 2 Multicenter, Randomized, Doubleblind, Placebo-Controlled, Dose Range Finding Study to Evaluate the Efficacy and Safety of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects Who Have Diabetic Foot . . .

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date07/20/16 → 07/19/17

Funding

  • Celgene Corporation: $13,000.00